Cormorant Asset Management, LP Diversified Active

CIK: 0001583977 · Show all filings

Period: Q1 2025 (← Previous) (Next →)

Filing Date: May 15, 2025

Total Value ($000): $1,329,947 (100.0% shares, 0.0% debt)

Holdings (44)

MLTX MOONLAKE IMMUNOTHERAPEUTICS 25.0%
Value ($000) $331,866 Shares 8,494,151 Est. Cost $12.22 Unrealized +252.6%
EWTX EDGEWISE THERAPEUTICS INC 6.8%
Value ($000) $90,244 Shares 4,101,992 Est. Cost $24.07 Unrealized +9.0%
BBIO BRIDGEBIO PHARMA INC 5.2%
Value ($000) $69,140 Shares 2,000,000 Est. Cost $20.96 Unrealized +60.9%
ACLX ARCELLX INC 5.2%
Value ($000) $68,880 Shares 1,050,000 Est. Cost $25.75 Unrealized +163.1%
PRAX PRAXIS PRECISION MEDICINES I 5.0%
Value ($000) $66,083 Shares 1,745,000 Est. Cost $54.23 Unrealized +15.2%
NAMS NEWAMSTERDAM PHARMA COMPANY 4.3%
Value ($000) $57,828 Shares 2,825,000 Est. Cost $20.31 Unrealized +9.5%
JANX JANUX THERAPEUTICS INC 4.1%
Value ($000) $54,000 Shares 2,000,000 Est. Cost $40.93 Unrealized -7.9%
EYPT EYEPOINT PHARMACEUTICALS INC 3.4%
Value ($000) $45,122 Shares 8,325,000 Est. Cost $11.03 Unrealized -36.6%
INSM INSMED INC 3.0%
Value ($000) $40,052 Shares 525,000 Est. Cost $36.03 Unrealized +112.3%
DRUG BRIGHT MINDS BIOSCIENCES INC 2.9%
Value ($000) $38,210 Shares 1,059,331 Est. Cost $35.19 Unrealized +4.0%
BBOT HELIX ACQUISITION CORP II 2.5%
Value ($000) $32,872 Shares 2,909,000 Est. Cost $10.35 Unrealized +3.8%
CNTA CENTESSA PHARMACEUTICALS PLC 2.4%
Value ($000) $32,522 Shares 2,261,600 Est. Cost $13.13 Unrealized —
— MERUS N V 2.3%
Value ($000) $31,147 Shares 740,000 Est. Cost $47.13 Unrealized —
RAPP RAPPORT THERAPEUTICS INC 2.2%
Value ($000) $29,497 Shares 2,940,921 Est. Cost $23.15 Unrealized -43.9%
AXSM AXSOME THERAPEUTICS INC 2.2%
Value ($000) $29,158 Shares 250,000 Est. Cost $74.04 Unrealized +53.9%
PHVS PHARVARIS N V 1.7%
Value ($000) $23,023 Shares 1,466,460 Est. Cost $21.48 Unrealized -21.5%
GHRS GH RESEARCH PLC 1.7%
Value ($000) $22,165 Shares 2,009,482 Est. Cost $13.91 Unrealized -19.6%
ARQT ARCUTIS BIOTHERAPEUTICS INC 1.6%
Value ($000) $21,114 Shares 1,350,000 Est. Cost $7.71 Unrealized +82.6%
TARS TARSUS PHARMACEUTICALS INC 1.5%
Value ($000) $20,548 Shares 400,000 Est. Cost $21.36 Unrealized +131.4%
SPRY ARS PHARMACEUTICALS INC 1.5%
Value ($000) $20,128 Shares 1,600,000 Est. Cost $12.65 Unrealized -4.9%
CRNX CRINETICS PHARMACEUTICALS IN 1.5%
Value ($000) $20,124 Shares 600,000 Est. Cost $24.75 Unrealized +50.9%
CGON CG ONCOLOGY INC 1.4%
Value ($000) $18,980 Shares 775,000 Est. Cost $39.73 Unrealized -29.2%
— CARGO THERAPEUTICS INC 1.0%
Value ($000) $13,762 Shares 3,381,277 Est. Cost $10.74 Unrealized —
ABVX ABIVAX SA 1.0%
Value ($000) $13,313 Shares 2,130,000 Est. Cost $10.70 Unrealized —
ALMS ALUMIS INC 1.0%
Value ($000) $13,185 Shares 2,147,396 Est. Cost $13.30 Unrealized -56.3%
CRBP CORBUS PHARMACEUTICALS HLDGS 0.9%
Value ($000) $12,611 Shares 2,375,000 Est. Cost $28.57 Unrealized -69.1%
RNAM AVIDITY BIOSCIENCES INC 0.9%
Value ($000) $11,808 Shares 400,000 Est. Cost $37.44 Unrealized -16.8%
— METSERA INC 0.8%
Value ($000) $10,888 Shares 400,000 Est. Cost $27.22 Unrealized —
ENGN ENGENE HOLDINGS INC 0.8%
Value ($000) $10,410 Shares 2,323,595 Est. Cost $9.69 Unrealized -35.9%
BIOA BIOAGE LABS INC 0.7%
Value ($000) $9,887 Shares 2,629,529 Est. Cost $18.97 Unrealized -75.6%
RYTM RHYTHM PHARMACEUTICALS INC 0.6%
Value ($000) $7,946 Shares 150,000 Est. Cost $19.33 Unrealized +187.1%
OKUR ONKURE THERAPEUTICS INC 0.6%
Value ($000) $7,902 Shares 1,837,739 Est. Cost $15.14 Unrealized -62.9%
BMEA BIOMEA FUSION INC 0.6%
Value ($000) $7,606 Shares 3,570,872 Est. Cost $17.07 Unrealized -80.0%
KRRO KORRO BIO INC 0.5%
Value ($000) $6,621 Shares 380,303 Est. Cost $29.65 Unrealized 0.0%
PCVX VAXCYTE INC 0.5%
Value ($000) $6,608 Shares 175,000 Est. Cost $53.56 Unrealized +49.3%
AARD AARDVARK THERAPEUTICS INC 0.5%
Value ($000) $6,009 Shares 800,189 Est. Cost $11.23 Unrealized 0.0%
MBX MBX BIOSCIENCES INC 0.4%
Value ($000) $5,166 Shares 700,000 Est. Cost $22.87 Unrealized -53.8%
NAMS NEWAMSTERDAM PHARMA COMPANY 0.4%
Value ($000) $5,118 Shares 250,000 Est. Cost $20.31 Unrealized +9.5%
ELVN ENLIVEN THERAPEUTICS INC 0.4%
Value ($000) $4,920 Shares 250,000 Est. Cost $25.92 Unrealized -17.0%
JANX JANUX THERAPEUTICS INC 0.3%
Value ($000) $4,050 Shares 150,000 Est. Cost $40.93 Unrealized -7.9%
PLRX PLIANT THERAPEUTICS INC 0.3%
Value ($000) $4,050 Shares 3,000,000 Est. Cost $6.07 Unrealized 0.0%
KALA KALA BIO INC 0.3%
Value ($000) $3,455 Shares 603,027 Est. Cost $6.30 Unrealized +20.1%
STOK STOKE THERAPEUTICS INC 0.1%
Value ($000) $1,690 Shares 254,161 Est. Cost $26.85 Unrealized -65.3%
BHVN BIOHAVEN LTD 0.0%
Value ($000) $240 Shares 10,000 Est. Cost $43.60 Unrealized -19.1%